FDA Digital Health Advisory Committee
The FDA is now accepting applications for the Digital Health Advisory Committee!
What Is the Goal of the Digital Health Advisory Committee?
Digital Health is a rapidly evolving, cross-cutting space that spans a wide range of technologies, such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
To support safe and effective regulation of digital health technologies while encouraging innovation, the FDA is establishing a Digital Health Advisory Committee to consider this topic and related issues, and to solicit views from technical and scientific subject matter experts from diverse disciplines and backgrounds.
The Digital Health Advisory Committee will advise the Commissioner of Food and Drugs on issues related to Digital Health Technologies (DHTs), and FDA policies and regulations about these technologies, providing relevant expertise and perspective to improve the FDA's understanding of the benefits, risks, and clinical outcomes associated with use of DHTs, as well as identifying risks, barriers, or unintended consequences that could result from proposed or established FDA policy or regulation for topics related to DHTs. This also may include advice on the use of DHTs in clinical trials or post-market studies subject to the FDA's regulation.
Committee Membership
The Committee shall consist of a core of 9 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of digital health. The number of temporary members selected for a particular meeting will depend on the meeting topic.
Meetings of the Committee and its subcommittees will be conducted according to the Federal Advisory Committee Act, other applicable laws and policies of the U.S. Department of Health and Human Services.
How to Apply to Become a Member of the Digital Health Advisory Committee
The FDA is looking to solicit views from technical and scientific subject matter experts from diverse disciplines and backgrounds, including both women and men, members of all racial and ethnic groups, and individuals with and without disabilities, for this advisory committee and, therefore encourages nominations of appropriately qualified candidates from these groups.
For those interested in serving or nominating a representative to serve as a voting or non-voting member of the FDA's Digital Health Advisory Committee, please either submit your nomination electronically by accessing the FDA Advisory Committee Membership Nomination Portal or by mail to:
Advisory Committee Oversight and Management Staff
Food and Drug Administration
10903 New Hampshire Ave.
Bldg. 32, Rm. 5103
Silver Spring. 20993-0002.
Nominations should be submitted no later than December 11, 2023.
Applications should include a current, complete résumé or curriculum vitae for each nominee, including a current business and home address, telephone number, and e-mail address if available.
Information about becoming a member on an FDA advisory committee can also be obtained by visiting FDA Advisory Committees.
Federal Register Notices
Contact Information
James Swink
Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Ave.
Bldg. 66
Silver Spring, MD 20993-0002
telephone:301-796-6313
fax: 301-847-8510
e-mail: james.swink@fda.hhs.gov